文献速递眼整形与眼眶

赖氨酰氧化酶样蛋白3在眼眶成纤维细胞中参与格雷夫斯眼病发病机制的作用

Role of Lysyl Oxidase-Like Protein 3 in the Pathogenesis of Graves' Orbitopathy in Orbital Fibroblasts.
PubMed 文献 · Invest Ophthalmol Vis Sci · 2024-01-01

该研究比较了格雷夫斯眼病(GO)患者(n=18)与健康对照(n=15)眼眶组织中LOX家族五个亚型的转录水平,发现LOX和LOXL3在GO组织中高表达;在GO成纤维细胞中,沉默LOXL3可减轻IL-1β诱导的促炎细胞因子和TGF-β诱导的促纤维化蛋白产生,并抑制脂肪细胞分化,提示LOXL3是GO的潜在治疗靶点。

要点

  • GO患者眼眶组织中LOX和LOXL3转录水平高于健康对照。
  • IL-1β、TGF-β和IGF-1刺激可增加GO成纤维细胞中LOXL3信使RNA表达。
  • 沉默LOXL3可减轻炎症因子和纤维化蛋白产生,并抑制脂肪细胞分化。

核心结论

  • LOXL3在GO发病机制中起关键作用,抑制LOXL3可减少炎症细胞因子产生、纤维化蛋白表达及成纤维细胞向脂肪细胞分化,本研究凸显LOXL3作为GO潜在治疗靶点。

研究设计与样本

  • 研究采用定量实时聚合酶链反应比较GO患者(n=18)与健康对照(n=15)眼眶组织外植体中LOX家族五个亚型的转录水平,并用蛋白质印迹法评估LOXL3抑制对IL-1β诱导的促炎细胞因子、TGF-β诱导的促纤维化蛋白、细胞内信号分子及脂肪生成标志物的影响,用油红O染色鉴定脂肪细胞分化。

主要发现

  • GO组织中LOX和LOXL3转录水平高。
  • IL-1β、TGF-β和胰岛素样生长因子-1刺激显著增加GO成纤维细胞中LOXL3信使RNA表达。
  • 沉默LOXL3减弱IL-1β诱导的促炎细胞因子(IL-6、IL-8和细胞间黏附分子-1)产生及TGF-β诱导的促纤维化蛋白(纤连蛋白、胶原1α和平滑肌肌动蛋白α)产生。
  • 沉默LOXL3还降低IL-1β或TGF-β诱导的磷酸化核因子κB、蛋白激酶B、细胞外信号调节激酶和c-Jun N端激酶表达。
  • 沉默LOXL3抑制脂肪细胞分化及脂肪生成转录因子(瘦素、AP-2、过氧化物酶体增殖物激活受体γ和CCAAT/增强子结合蛋白)表达。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: The lysyl oxidase (LOX) family has been implicated in the pathogenesis of diseases caused by inflammation and fibrosis. Therefore, we aimed to examine the role of lysyl oxidase-like protein 3 (LOXL3) in Graves' orbitopathy (GO) pathogenesis and its potential as a treatment target. METHODS: Quantitative real-time polymerase chain reaction compared the transcript levels of the five LOX family subtypes in orbital tissue explants obtained from patients with GO (n = 18) and healthy controls (n = 15). The effects of LOXL3 inhibition on interleukin (IL)-1β-induced proinflammatory cytokines, transforming growth factor (TGF)-β-induced profibrotic proteins, intracellular signaling molecules, and adipogenic markers were evaluated using Western blotting. Adipogenic differentiation was identified using Oil Red O staining. RESULTS: LOX and LOXL3 transcript levels were high in GO tissues. Stimulation with IL-1β, TGF-β, and insulin-like growth factor-1 significantly increased LOXL3 messenger RNA expression in GO fibroblasts. Furthermore, silencing LOXL3 attenuated the IL-1β-induced production of proinflammatory cytokines (IL-6, IL-8, and intercellular adhesion molecule-1) and TGF-β-induced production of profibrotic proteins (fibronectin, collagen 1α, and alpha-smooth muscle actin). It also reduced the IL-1β or TGF-β-induced expression of phosphorylated nuclear factor kappa-light-chain-enhancer of activated B cells, protein kinase B, extracellular signal-regulated kinase, and c-Jun N-terminal kinase. Additionally, LOXL3 silencing suppressed adipocyte differentiation and the expression of adipogenic transcription factors (leptin, AP-2, peroxisome proliferator-activated receptor gamma, and CCAAT/enhancer-binding protein). CONCLUSIONS: LOXL3 is crucial in GO pathogenesis. LOXL3 inhibition reduced inflammatory cytokine production, fibrotic protein expression, and fibroblast differentiation into adipocytes. This study highlights LOXL3 as a potential therapeutic target for GO.

来源:Invest Ophthalmol Vis Sci,查看原文。版权归原作者所有。

引用

  1. Park SH, Choi SH, Park HY, et al. Role of Lysyl Oxidase-Like Protein 3 in the Pathogenesis of Graves' Orbitopathy in Orbital Fibroblasts. Invest Ophthalmol Vis Sci. 2024. PMID: 39546293. doi:10.1167/iovs.65.13.33

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。